TY  - GEN
N2  - "Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"--
AB  - "Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"--
T1  - Biosimilars :design and analysis of follow-on biologics /
DA  - 2014.
CY  - Boca Raton :
AU  - Chow, Shein-Chung,
VL  - 60
CN  - RS380
PB  - Taylor & Francis,
PP  - Boca Raton :
PY  - 2014.
N1  - "A Chapman & Hall book."
ID  - 1400033
KW  - Pharmaceutical biotechnology.
KW  - Pharmaceutical biotechnology industry.
KW  - Drugs
KW  - Pharmaceutical policy.
KW  - Biological products.
TI  - Biosimilars :design and analysis of follow-on biologics /
LK  - https://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=1316405
UR  - https://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=1316405
ER  -